Cite
HARVARD Citation
Chakraborty, S. et al. (2021). Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin. Cancer letters. pp. 164-170. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chakraborty, S. et al. (2021). Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin. Cancer letters. pp. 164-170. [Online].